ES451135A1 - Dithiolanes and dithianes - Google Patents

Dithiolanes and dithianes

Info

Publication number
ES451135A1
ES451135A1 ES451135A ES451135A ES451135A1 ES 451135 A1 ES451135 A1 ES 451135A1 ES 451135 A ES451135 A ES 451135A ES 451135 A ES451135 A ES 451135A ES 451135 A1 ES451135 A1 ES 451135A1
Authority
ES
Spain
Prior art keywords
alkyl
chain
carbon atoms
hydroxyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES451135A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES451135A1 publication Critical patent/ES451135A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Novel sulphur-containing compounds which have coronary-dilating properties, of the formula < IMAGE > in which R represents a radical of the formula < IMAGE > or < IMAGE > R1, R2 and R3 represent hydrogen, halogen, lower alkyl, lower alkoxy, aryl-lower-alkoxy, aryloxy, phenyl, nitro, amino, lower alkylthio, trifluoromethyl, hydroxyl, cyano, di-lower alkylamino, lower alkanoylamino, carboxyl, lower alkoxycarbonyl, lower alkylsulphonyl, hydroxymethyl, lower alkanoyloxy, amido, lower alkanoyl, sulphamoyl, mono- or di-lower-alkyl-sulphamoyl, aminocarbonyloxy, mono- or di-lower-alkyl-aminocarbonyloxy, lower-alkyl-amino-lower-alkyl, or two adjacent radicals together represent methylenedioxy, ethylenedioxy or butadien-1,3-yl-1,4-ene, R4 represents hydrogen or lower alkyl, R5, R6 and R7 represent hydrogen, halogen, lower alkyl, lower alkoxy, hydroxyl or benzyloxy, or two adjacent radicals together represent methylenedioxy or ethylenedioxy, X represents a sulphur atom, SO or SO2, Y represents a straight-chain or branched, optionally hydroxyl-substituted aliphatic radical having 2-8 carbon atoms of which 2-4 carbon atoms are located in the chain, and Z represents a straight-chain or branched, optionally hydroxyl-substituted aliphatic radical having 1-8 carbon atoms of which 1-4 carbon atoms are located in the chain, m denotes the numbers 0 or 1 and n denotes the numbers 2 or 3, and acid addition salts thereof are described. These compounds are prepared by a suitable 2-substitution of compounds of the formula
ES451135A 1973-12-21 1976-09-01 Dithiolanes and dithianes Expired ES451135A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1803073A CH611614A5 (en) 1973-12-21 1973-12-21 Process for the preparation of heterocyclic compounds

Publications (1)

Publication Number Publication Date
ES451135A1 true ES451135A1 (en) 1977-08-16

Family

ID=4429892

Family Applications (5)

Application Number Title Priority Date Filing Date
ES433172A Expired ES433172A1 (en) 1973-12-21 1974-12-20 Dithiolanes and dithianes
ES451137A Expired ES451137A1 (en) 1973-12-21 1976-09-01 Dithiolanes and dithianes
ES451134A Expired ES451134A1 (en) 1973-12-21 1976-09-01 Dithiolanes and dithianes
ES451136A Expired ES451136A1 (en) 1973-12-21 1976-09-01 Dithiolanes and dithianes
ES451135A Expired ES451135A1 (en) 1973-12-21 1976-09-01 Dithiolanes and dithianes

Family Applications Before (4)

Application Number Title Priority Date Filing Date
ES433172A Expired ES433172A1 (en) 1973-12-21 1974-12-20 Dithiolanes and dithianes
ES451137A Expired ES451137A1 (en) 1973-12-21 1976-09-01 Dithiolanes and dithianes
ES451134A Expired ES451134A1 (en) 1973-12-21 1976-09-01 Dithiolanes and dithianes
ES451136A Expired ES451136A1 (en) 1973-12-21 1976-09-01 Dithiolanes and dithianes

Country Status (24)

Country Link
JP (1) JPS595594B2 (en)
AT (5) AT344693B (en)
AU (1) AU511714B2 (en)
BE (1) BE823625A (en)
CA (4) CA1057295A (en)
CH (3) CH611614A5 (en)
DD (1) DD116829A5 (en)
DE (2) DE2460593C3 (en)
DK (1) DK148323C (en)
ES (5) ES433172A1 (en)
FI (1) FI67216C (en)
FR (1) FR2255064B1 (en)
GB (3) GB1489087A (en)
HK (1) HK43380A (en)
HU (1) HU170429B (en)
IE (1) IE40788B1 (en)
IL (3) IL46146A (en)
LU (1) LU71530A1 (en)
NL (1) NL158496B (en)
NO (1) NO142669C (en)
PH (3) PH19393A (en)
SE (2) SE415763B (en)
YU (1) YU39311B (en)
ZA (1) ZA747526B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515173A1 (en) * 1981-10-28 1983-04-29 Delalande Sa 3-Methoxy 4-alkoxy benzaldehyde(s) - useful as intermediates for antibacterials, esp. trimethoprim and tetroxoprim
JPS60142297U (en) * 1984-02-29 1985-09-20 株式会社豊田自動織機製作所 Rotating device for swiveling driver's seat in forklift
JPS62171328U (en) * 1986-04-23 1987-10-30
DE3642331A1 (en) * 1986-12-11 1988-06-23 Basf Ag BASICLY SUBSTITUTED PHENYL ACETONITRILES, THEIR PRODUCTION AND THE MEDICINAL PRODUCTS CONTAINING THEM
US5434179A (en) * 1989-06-06 1995-07-18 Takeda Chemical Industries, Ltd. Method for improving brain function using cholinesterase-inhibiting aminoketone compounds
US7132547B2 (en) * 2001-12-28 2006-11-07 Takeda Pharmaceutical Company Limited Preventives/remedies for urinary disturbance
US20100137403A1 (en) * 2008-07-10 2010-06-03 Scott Malstrom Method for enhancing cognition or inhibiting cognitive decline

Also Published As

Publication number Publication date
LU71530A1 (en) 1976-11-11
NL7416507A (en) 1975-06-24
ATA38978A (en) 1978-10-15
DE2460593A1 (en) 1975-07-03
IL52843A0 (en) 1977-10-31
CH620921A5 (en) 1980-12-31
AU511714B2 (en) 1980-09-04
NL158496B (en) 1978-11-15
ES433172A1 (en) 1977-04-16
NO744615L (en) 1975-07-21
FI352774A (en) 1975-06-22
ES451134A1 (en) 1977-08-16
CH611614A5 (en) 1979-06-15
DE2463173C2 (en) 1987-01-29
GB1489088A (en) 1977-10-19
AT344693B (en) 1978-08-10
FR2255064B1 (en) 1978-03-24
AT349013B (en) 1979-03-12
FI67216C (en) 1985-02-11
SE434746B (en) 1984-08-13
IE40788L (en) 1975-06-21
AT349012B (en) 1979-03-12
AT350053B (en) 1979-05-10
HU170429B (en) 1977-06-28
CA1072966A (en) 1980-03-04
DD116829A5 (en) 1975-12-12
DK668174A (en) 1975-08-25
HK43380A (en) 1980-08-22
DK148323C (en) 1986-03-03
IE40788B1 (en) 1979-08-15
JPS5095267A (en) 1975-07-29
BE823625A (en) 1975-06-20
JPS595594B2 (en) 1984-02-06
CA1079290A (en) 1980-06-10
IL52844A0 (en) 1977-10-31
PH19393A (en) 1986-04-07
FI67216B (en) 1984-10-31
FR2255064A1 (en) 1975-07-18
NO142669B (en) 1980-06-16
AT349014B (en) 1979-03-12
ATA38878A (en) 1978-08-15
SE7416086L (en) 1975-06-23
PH13396A (en) 1980-03-28
IL46146A0 (en) 1975-03-13
IL46146A (en) 1980-09-16
GB1489087A (en) 1977-10-19
YU39311B (en) 1984-10-31
ES451136A1 (en) 1977-10-01
YU336874A (en) 1982-05-31
DE2460593B2 (en) 1979-01-18
AU7600874A (en) 1976-06-03
ATA38778A (en) 1978-08-15
CH620920A5 (en) 1980-12-31
ATA39178A (en) 1978-08-15
ATA1022674A (en) 1977-12-15
NO142669C (en) 1980-09-24
ES451137A1 (en) 1977-08-16
DE2460593C3 (en) 1979-09-13
ZA747526B (en) 1975-12-31
DK148323B (en) 1985-06-10
CA1086320A (en) 1980-09-23
AU3224278A (en) 1978-05-25
SE415763B (en) 1980-10-27
GB1489086A (en) 1977-10-19
CA1057295A (en) 1979-06-26
PH13326A (en) 1980-03-13

Similar Documents

Publication Publication Date Title
ES473074A1 (en) Thienothiazine derivatives, their preparation and compositions containing them.
ES463803A1 (en) O-[3-(4-Substituted-piperazin-1-yl)-2-hydroxypropyl]-hydroxylamines
ES451135A1 (en) Dithiolanes and dithianes
ES439927A1 (en) 7-Methoxy-6-thiatetracyclines and their preparation
SE7901729L (en) ETHIC ACID DERIVATIVES AND SET FOR THEIR PREPARATION
ES453264A1 (en) Daunorubicin derivatives
ES417559A1 (en) Imidazolidones
GR77088B (en)
GB1492171A (en) Derivatives of copolymers of carbon monoxide and ethylene
ES8106731A1 (en) 4,1-Benzoxazepines
ES425015A1 (en) N-(heteroaryl-methyl)-6,14-(endoethano or endoetheno)-7{60 -hydroxyalkyl-tetrahydro-nororipavines or-northebaines and salts thereof
ES445944A1 (en) 8-Amino-theophylline derivatives and therapeutic applications thereof
ES423699A1 (en) 3-oxyiminomethyl-cephalosporins
ES446325A1 (en) Process for the preparation of thieno(3,2-c) pyridine and derivatives thereof
ES424309A1 (en) N-(heteroaryl-methyl)-7{60 -acyl-6,14-(endoetheno or endoethano)-tetrahydro-nororipavines or-thebaines and salts thereof
ES451209A1 (en) Antispasmodic substituted sulphoximides
DE2963164D1 (en) Alpha-aminophenylacetic acid derivatives for use in the treatment of inflammations and novel alpha-aminophenylacetic acid derivatives
DK52383A (en) PROCEDURE FOR THE PREPARATION OF CARBACYCLINE DERIVATIVES
ES433957A1 (en) Novel phenothiazines
ES424835A1 (en) Alkyloxalyl amino-s-triazines
IE37963B1 (en) A disinfectant composition incorporating mono-oxycarboxylate salts of bis-biguanidines
FR2244526A1 (en) N,N&#39;-bis-(haloacyl)-hexahydro-1,4-diazepines - with antitumour activity and low toxicity
JPS5269491A (en) Preparation of high polymeric selenium compounds
ES461718A1 (en) Phenoxyphenoxyalkane derivatives process for their preparation and herbicidal compositions containing them
JPS5269490A (en) Preparation of high polymers containing selenium